- Home
- ADXN vs IMCC Comparison
ADXN vs IMCC Comparison
Compare ADXN & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADXN
- IMCC
- Stock Information
- Founded
- ADXN 2002
- IMCC 1980
- Country
- ADXN Switzerland
- IMCC Israel
- Employees
- ADXN N/A
- IMCC N/A
- Industry
- ADXN Biotechnology: Pharmaceutical Preparations
- IMCC Medicinal Chemicals and Botanical Products
- Sector
- ADXN Health Care
- IMCC Health Care
- Exchange
- ADXN Nasdaq
- IMCC Nasdaq
- Market Cap
- ADXN 9.4M
- IMCC 5.3M
- IPO Year
- ADXN N/A
- IMCC N/A
- Fundamental
- Price
- ADXN $9.38
- IMCC $2.91
- Analyst Decision
- ADXN Strong Buy
- IMCC
- Analyst Count
- ADXN 1
- IMCC 0
- Target Price
- ADXN $30.00
- IMCC N/A
- AVG Volume (30 Days)
- ADXN 17.4K
- IMCC 147.9K
- Earning Date
- ADXN 08-11-2025
- IMCC 08-13-2025
- Dividend Yield
- ADXN N/A
- IMCC N/A
- EPS Growth
- ADXN N/A
- IMCC N/A
- EPS
- ADXN 0.10
- IMCC N/A
- Revenue
- ADXN $278,508.00
- IMCC $37,894,737.00
- Revenue This Year
- ADXN $86.57
- IMCC $47.12
- Revenue Next Year
- ADXN N/A
- IMCC $12.83
- P/E Ratio
- ADXN $0.75
- IMCC N/A
- Revenue Growth
- ADXN N/A
- IMCC 12.68
- 52 Week Low
- ADXN $6.51
- IMCC $1.29
- 52 Week High
- ADXN $13.27
- IMCC $7.12
- Technical
- Relative Strength Index (RSI)
- ADXN 58.20
- IMCC 55.33
- Support Level
- ADXN $8.50
- IMCC $2.37
- Resistance Level
- ADXN $9.87
- IMCC $2.95
- Average True Range (ATR)
- ADXN 0.78
- IMCC 0.42
- MACD
- ADXN 0.05
- IMCC -0.03
- Stochastic Oscillator
- ADXN 72.46
- IMCC 56.93
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.